5590722186 · Annan naturvetenskaplig och teknisk forskning och utveckling · SOLNA
Source: Bolagsverket and Statistics Sweden (SCB), public registers, updated continuously. A missing value does not mean the company is inactive.
Neobiomics AB swung to profit in 2024: the net result was 3.8 MSEK, against -0.1 MSEK the period before. Fiscal 2024 brought revenue growth of 37.9 %, to 15.8 MSEK. Neobiomics AB lifted its operating margin from 0.6 % to 24.5 % in 2024. In 2024, net sales corresponded to roughly 1.8 MSEK per employee (9 employees).
Calculated by ArkivNord from filed annual reports. About the methodology
Positive signals from the latest annual accounts. See the Analysis tab for the full calculation behind each badge.
Net revenue
15.8 MSEK
▲ +38%Net result
3.8 MSEK
Employees
9
▲ +29%Per the signatures in the annual report for the fiscal year ending 2024-12-31.
This shows who signed the most recent parsed annual report — not a live register. Positions may have changed since filing.